Literature DB >> 15134562

New pathways for reactive oxygen species generation in inflammation and potential novel pharmacological targets.

F Di Virgilio1.   

Abstract

Oxidative agents are generated in large amounts during inflammation. These highly reactive intermediates interact with several extracellular and intracellular molecules and with each other, thus generating a complex network of responses culminating in an outcome that may be detrimental or beneficial for the host. Alongside with the well known systems involved in production of reactive oxygen species or reactive nitrogen species, such as the NADPH oxidase or the nitric oxide synthase, novel enzymatic pathways have been discovered. This has unveiled new targets and functions for oxidant species, and has prompted the development of innovative anti-inflammatory drugs. In the new integrate scenario stemming from these studies oxidant species are increasingly recognized as true messengers, and even their toxic effects are viewed as the result of the perversion of an otherwise physiological extra/intra cellular signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15134562     DOI: 10.2174/1381612043384727

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  16 in total

Review 1.  Molecular basis of intervertebral disc degeneration and herniations: what are the important translational questions?

Authors:  Tiffany Kadow; Gwendolyn Sowa; Nam Vo; James D Kang
Journal:  Clin Orthop Relat Res       Date:  2015-06       Impact factor: 4.176

Review 2.  Oxidative stress, inflammation, and cancer: how are they linked?

Authors:  Simone Reuter; Subash C Gupta; Madan M Chaturvedi; Bharat B Aggarwal
Journal:  Free Radic Biol Med       Date:  2010-09-16       Impact factor: 7.376

Review 3.  Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection.

Authors:  Joo Eun Jung; Gab Seok Kim; Hai Chen; Carolina M Maier; Purnima Narasimhan; Yun Seon Song; Kuniyasu Niizuma; Masataka Katsu; Nobuya Okami; Hideyuki Yoshioka; Hiroyuki Sakata; Christina E Goeders; Pak H Chan
Journal:  Mol Neurobiol       Date:  2010-02-17       Impact factor: 5.590

4.  TREM-2 mediates dendritic cell-induced NO to suppress Th17 activation and ameliorate chronic kidney diseases.

Authors:  Ching-Cheng Lin; Ti-Yung Chang; Yong-Chen Lu; Yun-Syuan Wu; Wei Huang; Wei-Chi Lo; Guan-Fu Liu; Wei-Chan Hsu; Pamela S Ohashi; Tak W Mak; Jong-Ling Fuh; Hui-Chen Chen; Der-Cherng Tarng; Nien-Jung Chen
Journal:  J Mol Med (Berl)       Date:  2022-05-09       Impact factor: 4.599

5.  Sialidase neu4 deficiency is associated with neuroinflammation in mice.

Authors:  Zehra Kevser Timur; Orhan Kerim Inci; Secil Akyildiz Demir; Volkan Seyrantepe
Journal:  Glycoconj J       Date:  2021-10-23       Impact factor: 2.916

Review 6.  An overview of underlying causes and animal models for the study of age-related degenerative disorders of the spine and synovial joints.

Authors:  Nam Vo; Laura J Niedernhofer; Luigi Aurelio Nasto; Lloydine Jacobs; Paul D Robbins; James Kang; Christopher H Evans
Journal:  J Orthop Res       Date:  2013-03-11       Impact factor: 3.494

7.  CK2 is a novel negative regulator of NADPH oxidase and a neuroprotectant in mice after cerebral ischemia.

Authors:  Gab Seok Kim; Joo Eun Jung; Kuniyasu Niizuma; Pak H Chan
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

Review 8.  Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure.

Authors:  Osama A Badary; Marwa S Hamza; Rajiv Tikamdas
Journal:  Drug Des Devel Ther       Date:  2021-05-03       Impact factor: 4.162

9.  Liposomal Antioxidants for Protection against Oxidant-Induced Damage.

Authors:  Zacharias E Suntres
Journal:  J Toxicol       Date:  2011-08-16

Review 10.  Dual effect of oxidative stress on leukemia cancer induction and treatment.

Authors:  Udensi K Udensi; Paul B Tchounwou
Journal:  J Exp Clin Cancer Res       Date:  2014-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.